Xiangdong Ma
- Topics
- Antimicrobial Peptides and Activities (3 papers)CRISPR and Genetic Engineering (3 papers)Enzyme Production and Characterization (3 papers)
In The Last Decade
Xiangdong Ma
22 papers receiving 392 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 298
- Biomedical Engineering 52
- Genetics 49
- Cancer Research 48
- Biotechnology 43
Countries citing papers authored by Xiangdong Ma
This map shows the geographic impact of Xiangdong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangdong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangdong Ma more than expected).
Fields of papers citing papers by Xiangdong Ma
This network shows the impact of papers produced by Xiangdong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangdong Ma. The network helps show where Xiangdong Ma may publish in the future.
Co-authorship network of co-authors of Xiangdong Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangdong Ma. A scholar is included among the top collaborators of Xiangdong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangdong Ma. Xiangdong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 66 | |
| 2 | CXCL5 contributes to the tumorigenicity of cervical cancer and is post-transcriptionally regulated by miR-577. | 10 |
| 3 | 109 | |
| 4 | 10 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 9 | |
| 8 | 8 | |
| 9 | 5 | |
| 10 | 32 | |
| 11 | 12 | |
| 12 | 1 | |
| 13 | 27 | |
| 14 | 2 | |
| 15 | [High expression of antimicrobial peptide Cecropin AD in Escherichia coli by fusion with EDDIE]. | 3 |
| 16 | 4 | |
| 17 | [A new plate method for screening of polysaccharide-degrading enzymes and their producing microorganisms]. | 5 |
| 18 | [Detection of expression of endometriosis-related cytokine and their receptor genes by cDNA microarray technique]. | 8 |
| 19 | [Progress of RASSF1A gene in neoplasms]. | 1 |
| 20 | A new method to determine α-amylase activity and its producing bacteria. | 1 |
About Xiangdong Ma
Xiangdong Ma is a scholar working on Biotechnology, Business and International Management and Microbiology, having authored 22 papers that have together received 396 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (3 papers), CRISPR and Genetic Engineering (3 papers) and Enzyme Production and Characterization (3 papers). The work is most often cited by research in Business and International Management (11 citations), Biotechnology (43 citations) and Molecular Biology (298 citations). Xiangdong Ma has collaborated with scholars based in China and Canada. Frequent co-authors include Lixin Ma, Yi Li, Biliang Chen, Shihui Yang, Wenfang Peng, Yanli Zheng, Baiyang Wang, Guoqing Cai, Wei Zou and Runxia Li. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and BMC Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.